Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Antidepressants for smoking cessation

Anisa Hajizadeh, Seth Howes, Annika Theodoulou, Elias M. Klemperer, Jamie Hartmann‐Boyce, Jonathan Livingstone‐Banks, Nicola Lindson

Cochrane Database of Systematic Reviews · 2023

Read source ↗ All evidence

Summary

BACKGROUND: The pharmacological profiles and mechanisms of antidepressants are varied. However, there are common reasons why they might help people to stop smoking tobacco: nicotine withdrawal can produce short-term low mood that antidepressants may relieve; and some antidepressants may have a specific effect on neural pathways or receptors that underlie nicotine addiction. OBJECTIVES: To assess the evidence for the efficacy, harms, and tolerability of medications with antidepressant properties in assisting long-term tobacco smoking cessation in people who smoke cigarettes. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialised Register, most recently on 29 April 2022. SELECTION CRITERIA: We included randomised controlled trials (RCTs) in people who smoked, comparing

Source type
Peer-reviewed study
DOI
10.1002/14651858.cd000031.pub6
Catalogue ID
SNmoj1y6vn-igkwm3
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.